Accessibility Menu
Durect logo

Durect(NASDAQ) DRRX

This security has been delisted. This page is retained for historical reference.

Durect last closing stock price
MetricPriceDate
Last closeUSD 1.912025-09-10
Durect stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.55%USD 1.942025-09-03
1 month+2.14%USD 1.872025-08-11
3 month+198.44%USD 0.642025-06-12
Year to date+154.67%USD 0.752024-12-31
1 year+27.33%USD 1.502024-09-10
3 year-70.55%USD 6.492022-09-09
5 year-88.06%USD 16.002020-09-11
Since inception-98.67%USD 144.062000-09-28

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

DRRX Financials

Key Financial Metrics (TTM)

Gross Margin

90.10%

Operating Margin

-903.91%

Net Income Margin

-845.96%

Return on Equity

-139.90%

Return on Capital

-166.82%

Return on Assets

-52.05%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$2.54M

Operating Income

-$16.73M

EBITDA

-$14.82M

Operating Cash Flow

-$13.96M

Capital Expenditure

-$7.00K

Free Cash Flow

-$13.97M

Cash & ST Invst.

$6.50M

Total Debt

$1.75M

Durect Performance Analysis

Durect annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 13,977,000N/A
20222022-12-31USD 19,283,00038.0%
20232023-12-31USD 2,590,000-86.6%
20242024-12-31USD 2,031,000-21.6%
Durect sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32024-09-30-11.2%
Q42024-12-31-76.5%
Q12025-03-31-29.1%
Q22025-06-3039.3%
Durect annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -1.61N/A
20222022-12-31USD -1.55-3.7%
20232023-12-31USD -1.21-22.3%
20242024-12-31USD -0.64-46.7%
Durect sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32024-09-30-16.7%
Q42024-12-31271.4%
Q12025-03-31-154.2%
Q22025-06-3043.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$447.00K

-79.4%

Gross Profit

$440.00K

-75.8%

Gross Margin

98.43%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

21

N/A

Net Income

-$2.27M

+38.8%

EBITDA

-$2.25M

+31.0%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Total Cash

$6.50M

-58.4%

Total Debt

$1.75M

-89.1%

Accounts Receivable

$511.00K

-49.5%

Inventory

$291.00K

-88.2%

Long Term Debt

$652.00K

-70.6%

Short Term Debt

$2.20M

-84.1%

Return on Assets

-52.05%

N/A

Return on Invested Capital

-1.51%

N/A

Free Cash Flow

-$1.76M

+52.0%

Operating Cash Flow

-$1.76M

+52.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SHOTRMG ML Sports Holdings
$9.82+0.00%
ZYNEZynerba Pharmaceuticals, Inc.
$1.30+2.36%
LIENChicago Atlantic BDC, Inc.
$9.53-1.24%
RPHMReneo Pharmaceuticals, Inc.
$18.20+952.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$8.00+0.04%
AALAmerican Airlines Group
$14.79-0.03%
PATHUiPath
$10.70-0.11%
NOKNokia
$10.28-0.03%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.